Ensign Peak Advisors, Inc Biomarin Pharmaceutical Inc Transaction History

Ensign Peak Advisors, Inc

  • $56.1 Billion
  • Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 67,863 shares of BMRN stock, worth $4.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,863
Previous 71,888 5.6%
Holding current value
$4.4 Million
Previous $5.92 Million 19.4%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $277,805 - $377,706
-4,025 Reduced 5.6%
67,863 $4.77 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $20,840 - $25,821
-280 Reduced 0.39%
71,888 $5.92 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $7.19 Million - $8.49 Million
-85,808 Reduced 54.32%
72,168 $6.3 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $2.9 Million - $3.75 Million
38,095 Added 31.78%
157,976 $15.2 Million
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $176,094 - $195,573
-2,070 Reduced 1.7%
119,881 $10.6 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $1.41 Million - $1.63 Million
16,252 Added 15.38%
121,951 $10.6 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $12 Million - $16 Million
-136,402 Reduced 56.34%
105,699 $10.3 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $1.82 Million - $2.45 Million
22,529 Added 10.26%
242,101 $25.1 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $10.6 Million - $12.5 Million
129,246 Added 143.09%
219,572 $18.6 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $3.21 Million - $3.9 Million
44,936 Added 99.0%
90,326 $7.49 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $579,384 - $722,982
-7,800 Reduced 14.66%
45,390 $3.5 Million
Q4 2021

Feb 11, 2022
BUY
$71.72 - $91.47 $3.81 Million - $4.87 Million
53,190 New
53,190 $4.7 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $1.2 Million - $1.48 Million
-16,459 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $1.18 Million - $2.16 Million
16,459 New
16,459 $1.25 Million
Q1 2020

May 11, 2020
SELL
$71.37 - $96.85 $752,953 - $1.02 Million
-10,550 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $678,048 - $911,203
10,550 New
10,550 $892,000

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email